Table 1.
Baseline characteristics of the axSpA patients.
| Total | 49 |
| Age in years (SD) | 34.1 (8.1) |
| Males | 28 (57.1%) |
| Place of birth | |
| - Beirut (capital) | 11 (22.4%) |
| - Rest of the country | 38 (77.6%) |
| Disease | |
| - r-axSpA | 22 (45%) |
| - nr-axSpA | 27 (55%) |
| Symptom duration (SD) | 25.3 months (16) |
| Pain site | |
| - Buttocks | −42 (86%) |
| - Lumbar spine | −45 (92%) |
| - Thoracic spine | −7 (14%) |
| - Cervical spine | −13 (27%) |
| Extra-articular manifestations | |
| - Enthesitis | −11 (22%) |
| - Psoriasis | −7 (14%) |
| - Peripheral arthritis | −5 (12%) |
| - Uveitis | −4 (8%) |
| - IBD | −4 (8%) |
| - Infection | −1 (2%) |
| Positive family history of SpA | 9 (18%) |
| BASDAI, mean (SD) | 4.3 (2.1) |
| ASDAS-CRP, mean (SD) | 3.4 (1.2) |